Across TCGA pan-cancer cohorts, RPL7P26 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated RPL7P26 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher RPL7P26 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL7P26 expression acts as an unfavorable survival marker, although some lineages such as BRCA and THYM show a favorable association.

BRCA, LUSC, and UVM are the cancer types where RPL7P26 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	DFS	Tertile	III,IV	0.956	0.810	<.001	55	view →
LUSC	DFS	Median	III,IV	0.284	0.929	<.001	38	view →
UVM	DFS	Median	III,IV	0.198	0.749	.003	35	view →
OV	OS	Tertile	All	0.800	0.869	.013	26	view →
THYM	DFS	Median	II,III,IV	0.971	0.804	.001	23	view →
ACC	DFS	Median	II,III,IV	0.470	0.765	.003	11	view →
SARC	OS	Median	All	0.410	0.625	.007	11	view →
CHOL	DFS	Tertile	III,IV	0.172	0.779	.024	9	view →
SKCM	DFS	Median	II,III,IV	0.164	0.308	.005	7	view →
LAML	DFS	Median	All	0.444	0.300	.027	6	view →
DLBC	DFS	Median	IV	0.195	0.923	.038	5	view →
COAD	DFS	Tertile	All	0.575	0.456	.037	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

Exploration

Same gene, other analysis: RPL7P26 tumor-vs-normal RNA expression · all RPL7P26 data types